Connor, Clark & Lunn Investment Management (CC&L)’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-26,337
Closed -$1.34M 1648
2025
Q1
$1.34M Buy
26,337
+2,705
+11% +$138K 0.01% 850
2024
Q4
$1.07M Sell
23,632
-15,278
-39% -$690K ﹤0.01% 907
2024
Q3
$1.44M Sell
38,910
-15,659
-29% -$581K 0.01% 757
2024
Q2
$1.67M Buy
+54,569
New +$1.67M 0.01% 704
2023
Q1
Sell
-66,347
Closed -$2.53M 1411
2022
Q4
$2.53M Sell
66,347
-9,336
-12% -$356K 0.01% 488
2022
Q3
$3.8M Buy
75,683
+65,600
+651% +$3.29M 0.02% 375
2022
Q2
$404K Buy
+10,083
New +$404K ﹤0.01% 822
2021
Q1
Sell
-4,011
Closed -$245K 1069
2020
Q4
$245K Buy
+4,011
New +$245K ﹤0.01% 806
2019
Q3
Sell
-19,907
Closed -$896K 1061
2019
Q2
$896K Sell
19,907
-24,509
-55% -$1.1M 0.01% 589
2019
Q1
$1.67M Sell
44,416
-64,574
-59% -$2.43M 0.01% 446
2018
Q4
$3.74M Sell
108,990
-35,347
-24% -$1.21M 0.03% 315
2018
Q3
$6.78M Sell
144,337
-130,585
-47% -$6.14M 0.04% 269
2018
Q2
$9.27M Sell
274,922
-244,156
-47% -$8.24M 0.05% 223
2018
Q1
$14M Buy
519,078
+13,175
+3% +$357K 0.09% 166
2017
Q4
$8.44M Buy
505,903
+76,978
+18% +$1.28M 0.05% 226
2017
Q3
$8.58M Buy
428,925
+392,850
+1,089% +$7.86M 0.05% 225
2017
Q2
$661K Sell
36,075
-36,750
-50% -$673K ﹤0.01% 555
2017
Q1
$717K Buy
+72,825
New +$717K ﹤0.01% 554
2016
Q4
Sell
-51,210
Closed -$717K 966
2016
Q3
$717K Sell
51,210
-12,790
-20% -$179K 0.01% 515
2016
Q2
$449K Buy
64,000
+50,900
+389% +$357K ﹤0.01% 605
2016
Q1
$84K Sell
13,100
-1,500
-10% -$9.62K ﹤0.01% 776
2015
Q4
$473K Sell
14,600
-11,700
-44% -$379K ﹤0.01% 551
2015
Q3
$702K Sell
26,300
-8,800
-25% -$235K 0.01% 466
2015
Q2
$1.69M Sell
35,100
-1,400
-4% -$67.4K 0.02% 262
2015
Q1
$2.22M Buy
36,500
+23,200
+174% +$1.41M 0.02% 218
2014
Q4
$689K Buy
+13,300
New +$689K 0.01% 348